Newsroom

Articles

Mini-Lab presentation at ECCMID 2022 in Lisbon

MSF and the Mini-Lab team were present at the 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), which took place in Lisbon, Portugal from 23 to 26 April 2022.

Read more
Articles

The Mini-Lab is deployed in Aweil, South Sudan in April 2022

The Mini-Lab has been deployed in Aweil, South Sudan in April 2022.

Read more
Articles

Launch of the internal deployment plan

Mini-Lab is now ready to be deployed within the MSF Movement.

Read more
Articles

Mini-Lab collaborates with WHONET

MSF is pleased to announce the partnership between MSF and WHONET to integrate WHONET's expertise into the Laboratory Information Management System (Mini-LIMS) to facilitate the interpretation of antibiotic susceptibility tests (AST)

Read more
Articles

Deployment of the second Mini-LAB pilot on the field in Bangui (Central African Republic)

Read more

Headline

MSF Foundation in Video

  • WPC Dubai 2023 fondation msf
    Vidéos

    The MSF Foundation 3D program at the WPC World Physiotherapy Congress in Dubai

  • UneEN-Sica
    Vidéos

    Antibiogo : Routine implementation within the MSF Sica Laboratory in Bagui, CAR

News

  • Articles

    Cervical cancer : when AI helps improve diagnosis

    Cervical cancer is the second deadliest cancer in low- and middle-income countries (1). In Malawi in East Africa, where MSF operates, over 4,000 Malawian women fall sick with cervical cancer every year. With 2,905 deaths due to cervical cancer in 2020, the country also had the second highest rate of mortality (2). How can we explain such a high mortality rate from this disease which, in high-income countries, is easily preventable and generally less deadly?  The reasons include limited access to prevention and screening, and diagnoses that are not always reliable.

     

    Clara Nordon, Director of the MSF Foundation, has just got back from a visit to Malawi with the MSF teams and tells us about the project led by the Foundation. Code name: AI4CC

    Read more
  • Utilisation d'Antibiogo au laboratoire MSF, hôpital CHK.Kinshasa. République Démocratique du Congo
    Articles

    Antibiogo is already implemented in routine in DRC and Jordan, and soon within other MSF’s Labs !

    Read more

Publications

  • Publications

    Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial

    Read more
  • Publications

    Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial

    Read more

Press Review

No news for now.